Elisabeth Bjork - 27 Aug 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
Issuer symbol
RCKT
Transactions as of
27 Aug 2025
Net transactions value
+$34,100
Form type
4
Filing time
27 Aug 2025, 20:54:13 UTC
Previous filing
18 Jul 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bjork Elisabeth Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork 27 Aug 2025 0001810406

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Purchase $34,100 +10,000 +33% $3.41 40,000 27 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.